Systemic inflammation is increasingly recognized as a key contributor to acute heart failure (AHF) and is associated with adverse outcomes. However, its relationship with objective imaging markers of cardiac dysfunction and pulmonary congestion in AHF remains incompletely understood.
This study examined as...
Z. Juma, F. S. Davidovski, C. Espersen et al.· European Heart Journal· 0 citations
The clinical relevance of left atrial (LA) dysfunction in acute heart failure (AHF) is unclear. Whether LA strain reflects disease mechanisms and predicts adverse outcomes in this heterogeneous population remains insufficiently investigated.
The aim was to examine the relationships between LA reservoir str...
M. Pedersen, F. Davidovski, C. Espersen et al.· European Heart Journal· 0 citations
Metabolic dysfunction associated steatotic liver disease (MASLD) is closely linked with cardiometabolic risk, but how cardiometabolic burden translates into early cardiac dysfunction in MASLD remains incompletely characterized. We evaluated whether higher cardiovascular-kidney-metabolic (CKM) syndrome stage was a...
A. Stanchev, F. S. Davidovski, C. E. Caroline Espersen et al.· European Heart Journal· 0 citations
Abstract Introduction Sex differences in chronic heart failure are well established, but corresponding differences in acute heart failure (AHF), particularly in multimodal imaging findings and short-term recovery, remain incompletely characterized. Methods In this prospective observational study, 567 adults hospitalize...
A. Khoraizat, F. Davidovski, C. Espersen et al.· ESC Heart Failure· 0 citations
Acute heart failure (AHF) is a major global health challenge, yet the relationship between New York Heart Association (NYHA) classification and objective markers such as echocardiography, lung ultrasound (LUS), and biomarkers remains unclear.
A. Al-Rubai, F. Davidovski, C. Espersen et al.· Echocardiography· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.